Clinical Trial Update: Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating a triplet regimen of carfilzomib, Iberdomide (CC-220), and dexamethasone (KID) in transplant-e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Kyprolis (carfilzomib)
• iberdomide (iberdomide)

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: RECRUITING